FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313362564> ?p ?o ?g. }

• W4313362564 endingPage "83" @default.
• W4313362564 startingPage "83" @default.
• W4313362564 abstract "Background: ICIs have dramatically improved patient outcomes in different malignancies. However, the impact of liver metastases (LM) and number of metastatic sites (MS) remains unclear in patients treated with single-agent anti-PD(L)1. Methods: We aimed to assess the prognostic impact of LM and MS number on progression-free survival (PFS) and overall survival (OS) in a large single-arm retrospective multicentric cohort (IMMUCARE) of patients treated with anti-PD(L)-1 for different solid tumors. Results: A total of 759 patients were enrolled from January 2012 to October 2018. The primary tumor types were non-small cell lung cancer (71%), melanoma (19%), or urologic cancer (10%). At the time of ICI initiation, 167 patients (22%) had LM and 370 patients (49%) had more than MS. LM was associated with a shorter median PFS of 1.9 months (95% CI: 1.8−2.5) vs. 4.0 months (95% CI: 3.6−5.4) in patients without LM (p < 0.001). The median OS of patients with LM was of 5.2 months (95% CI: 4.0−7.7) compared with 12.8 months (95% CI: 11.2−15.1) (p < 0.001). Interestingly, LM were not associated with shorter PFS, or OS compared to other MS types (brain, bone, or lung) in patients with only one MS. Patients with multiple MS also had poor clinical outcomes compared to patients with only one MS. The presence of LM and MS number were independent prognostic factors on overall survival. Conclusion: The presence of LM or multiple MS were associated with poorer survival outcomes in patients treated with anti-PD(L)-1." @default.
• W4313362564 created "2023-01-06" @default.
• W4313362564 creator A5001567551 @default.
• W4313362564 creator A5001985433 @default.
• W4313362564 creator A5016680807 @default.
• W4313362564 creator A5027074034 @default.
• W4313362564 creator A5039328991 @default.
• W4313362564 creator A5042100249 @default.
• W4313362564 creator A5052834446 @default.
• W4313362564 creator A5055254199 @default.
• W4313362564 creator A5057418532 @default.
• W4313362564 creator A5073133195 @default.
• W4313362564 creator A5079550043 @default.
• W4313362564 creator A5091147497 @default.
• W4313362564 date "2022-12-29" @default.
• W4313362564 modified "2023-09-30" @default.
• W4313362564 title "Impact of Liver Metastases and Number of Metastatic Sites on Immune-Checkpoint Inhibitors Efficacy in Patients with Different Solid Tumors: A Retrospective Study" @default.
• W4313362564 cites W1147694683 @default.
• W4313362564 cites W1573433003 @default.
• W4313362564 cites W1919811975 @default.
• W4313362564 cites W2009519656 @default.
• W4313362564 cites W2012295597 @default.
• W4313362564 cites W2024564253 @default.
• W4313362564 cites W2038982031 @default.
• W4313362564 cites W2044835625 @default.
• W4313362564 cites W2074238518 @default.
• W4313362564 cites W2080682920 @default.
• W4313362564 cites W2102297555 @default.
• W4313362564 cites W2103257412 @default.
• W4313362564 cites W2130629599 @default.
• W4313362564 cites W2141444851 @default.
• W4313362564 cites W2171492233 @default.
• W4313362564 cites W2198093519 @default.
• W4313362564 cites W2343165495 @default.
• W4313362564 cites W2533419167 @default.
• W4313362564 cites W2560367415 @default.
• W4313362564 cites W2572174216 @default.
• W4313362564 cites W2599658522 @default.
• W4313362564 cites W2607272476 @default.
• W4313362564 cites W2760661635 @default.
• W4313362564 cites W2796582438 @default.
• W4313362564 cites W2805354595 @default.
• W4313362564 cites W2887050785 @default.
• W4313362564 cites W2895465591 @default.
• W4313362564 cites W2903686952 @default.
• W4313362564 cites W2911638494 @default.
• W4313362564 cites W2919428266 @default.
• W4313362564 cites W2971136376 @default.
• W4313362564 cites W2978554061 @default.
• W4313362564 cites W2979129241 @default.
• W4313362564 cites W3010839046 @default.
• W4313362564 cites W3017626158 @default.
• W4313362564 cites W3017958602 @default.
• W4313362564 cites W3047382685 @default.
• W4313362564 cites W3093473233 @default.
• W4313362564 cites W3107646830 @default.
• W4313362564 cites W3111270650 @default.
• W4313362564 cites W3178058903 @default.
• W4313362564 cites W3194840426 @default.
• W4313362564 cites W3203802554 @default.
• W4313362564 cites W4200026971 @default.
• W4313362564 cites W4237816489 @default.
• W4313362564 doi "https://doi.org/10.3390/biomedicines11010083" @default.
• W4313362564 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36672591" @default.
• W4313362564 hasPublicationYear "2022" @default.
• W4313362564 type Work @default.
• W4313362564 citedByCount "1" @default.
• W4313362564 countsByYear W43133625642023 @default.
• W4313362564 crossrefType "journal-article" @default.
• W4313362564 hasAuthorship W4313362564A5001567551 @default.
• W4313362564 hasAuthorship W4313362564A5001985433 @default.
• W4313362564 hasAuthorship W4313362564A5016680807 @default.
• W4313362564 hasAuthorship W4313362564A5027074034 @default.
• W4313362564 hasAuthorship W4313362564A5039328991 @default.
• W4313362564 hasAuthorship W4313362564A5042100249 @default.
• W4313362564 hasAuthorship W4313362564A5052834446 @default.
• W4313362564 hasAuthorship W4313362564A5055254199 @default.
• W4313362564 hasAuthorship W4313362564A5057418532 @default.
• W4313362564 hasAuthorship W4313362564A5073133195 @default.
• W4313362564 hasAuthorship W4313362564A5079550043 @default.
• W4313362564 hasAuthorship W4313362564A5091147497 @default.
• W4313362564 hasBestOaLocation W43133625641 @default.
• W4313362564 hasConcept C121608353 @default.
• W4313362564 hasConcept C126322002 @default.
• W4313362564 hasConcept C141071460 @default.
• W4313362564 hasConcept C143998085 @default.
• W4313362564 hasConcept C167135981 @default.
• W4313362564 hasConcept C2776256026 @default.
• W4313362564 hasConcept C2777658100 @default.
• W4313362564 hasConcept C3019894029 @default.
• W4313362564 hasConcept C502942594 @default.
• W4313362564 hasConcept C71924100 @default.
• W4313362564 hasConcept C72563966 @default.
• W4313362564 hasConcept C90924648 @default.
• W4313362564 hasConceptScore W4313362564C121608353 @default.
• W4313362564 hasConceptScore W4313362564C126322002 @default.
• W4313362564 hasConceptScore W4313362564C141071460 @default.
• W4313362564 hasConceptScore W4313362564C143998085 @default.

• next